Instylla Embrace - Hydrogel Embolic System (HES)

Embrace™ Hydrogel Embolic System (HES) consists of two low viscosity liquid precursors that polymerize intravascularly when simultaneously injected into blood vessels forming a soft, water-based PEG hydrogel, during the embolization procedure. Before use, the precursors are mixed with commercially available iodinated contrast media enabling radiopacity. The hydrogel contains no organic solvents in its formulation. Upon delivery, the hydrogel casts out the vasculature to create a rapid and durable occlusion. The hydrogel liquifies via hydrolysis over a period of approximately 6 months, and the hydrolysis products are absorbed and cleared via renal filtration.